Book Value per Share: pasitheaclinics.com (KTTA)
Pasithea Therapeutics management combines clinical expertise and science to combat depression via the immune system. The book value per share on the GURU.Markets chart illustrates asset dynamics, where 1.49 captures the current value of the indicator. Steady confidence from the medical community is coupled with the logistics risks of rare compounds, which could slow down international trials.
Pasithea Therapeutics Corp - analytical breakdowns and key metrics (KTTA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:pasitheaclinics.com, KTTA
Pasithea Therapeutics (KTTA) maintains a competitive advantage by attracting elite neurobiologists through a system of patent options, which directly impacts the capitalization of intellectual assets. An analysis of the book value per share demonstrates the residual value of equity after all liabilities are settled, allowing investors to assess the real financial stability of the business and the risk of equity impairment within the context of academic research.
Competitor analysis for Pasithea Therapeutics
Accounting Value per Share Biogen Corp BIIB|NBIX - Book Price of a Share|RGC: Book Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines PRAX|Share Book Value anavex.com|Book Value per Share CBLL|Book Value per Share PRTA (Prothena Corporation)|Net Assets per Single Share ALEC|Net Assets per Share Annexon Biosciences Inc. ANNX|Book Value per Share OMER (Omeros Corp.)|neurogene.com (NGNE) - Net Assets per Share|ACIU - Accounting Value per Share|Voyager Therapeutics Inc (VYGR) - Book Price of a Share|NMRA - Book Value per Share|Accounting Value of a Share Scilex Holding Company, Inc.|Tevogen Bio Holdings - Book Value per Share|Net Asset Value per Share alphacognition.com (ACOG)|Book Value per Share CGTX (Cognition Therapeutics)|IKT - Book Value per Share|Accounting Value per Share Cassava (SAVA)|Assertio Holdings, Inc. (ASRT) - Accounting Value of a Share|COYA - Accounting Value per Share|Vistagen (VTGN) - Book Price of a Share|OVID - Book Value per Share|Accounting Value of a Share Acumen Pharmaceuticals Inc.|CervoMed Inc - Book Value per Share|Net Asset Value per Share ATHE (alteritytherapeutics.com)|Net Assets per Single Share Clene|Accounting Value of a Share PepGen Inc PEPG|Jupiter Neurosciences Inc - Book Value per Share|RLMD: Book Value per Share|Net Assets per Single Share Annovis Bio Corp (ANVS)|Grace Therapeutics (GRCE) - Share Book Value|Book Value per Share AIFF (Firefly Neuroscience, Inc)|Net Asset Value per Share ANEW Medical, Inc. (KLTO)|Accounting Value per Share NRSN|Book Value per Share Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Value per Share MetaVia (MTVA)|Book Price of a Share NeurAxis Inc NRXS|Book Value per Share HSDT (Helius Medical Technologies Inc.)|PASG - Net Assets per Share|NEUP (bionomics.com.au) - Book Value per Share|NERV (Minerva Neurosciences Inc) - Accounting Value per Share|ATHA: Net Assets per Single Share|Net Assets per Share ADXN|Net Assets per Single Share ALZN|Book Value per Share cyclerion.com CYCN|Accounting Value per Share Protagenic Therapeutics, Inc. (PTIX)|CRGT - Book Price of a Share|Accounting Value per Share Avenue Therapeutics, Inc ATXI|BCLI - Book Price of a Share|CARA: Book Value per Share|CHRO (chromocell.com) - Book Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular|Longboard Pharma - Book Value per Share|Net Asset Value per Share Marinus Pharma MRNS|Accounting Value per Share NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value per Share|Net Assets per Single Share Sage Therapeutics (SAGE)|SNPX: Accounting Value of a Share|Net Assets per Single Share TRVN|VIGL (Vigil Neuroscience, Inc.) - Net Asset Value per Share|Net Assets per Single Share Anew Medical WENA|Share Book Value cerevel.com